Table 1.

Patient-Derived Samples Used for Xenograft Studies

AML ID	Cytogenetics	Cyto Risk	NPM	FLT3
AML1	NDa	ND	mutant	ND
AML2	t(9,6)	intermediate	ND	ND
AML3	normal	intermediate	WT	ITDb
AML4	11q23/MLL	ND	ND	ND
AML5	complex	poor	WT	ND
AML6	normal	intermediate	mutant	ITD
AML7	normal	intermediate	mutant	ITD
AML8	Del 7q+8 + 1	poor	WT	WT
AML9	normal	intermediate	mutant	ITD
AML10	complex	poor	ND	ND

^aNot determined.

^bInternal tandem duplication.